In order to understand the genome-wide reactions at transcript level resulting from knocking down NFATc1, we performed transcriptome profiling in the pancreatic cancer cell lines PANC-1, MiaPaCa-2 and AsPC1. The gene discussed is NFATC1; the disease is familial pancreatic carcinoma.